�����ƽ��

Opening the presentations, Assoc. Prof. Dr. Nguyen Quang Duat – Department of Gastroenterology & Hepatology – spoke about the importance of colorectal cancer screening, especially for individuals over 45 years old or those with risk factors such as a family history, chronic inflammatory bowel disease, or polyps. He emphasized that “Colorectal cancer can absolutely be detected early and cured if screened at the right time, with colonoscopy being the gold standard.” Thanks to modern equipment such as the Olympus EVIS EXERA III CV 190 HQ endoscopy system, detecting lesions as small as a few millimeters has become possible – opening the door to treatment at a very early stage.

Dr. Duat also detailed the essential tests in early diagnosis, such as stool tests, cancer marker tests, and genetic testing. At the end of his presentation, he presented specific clinical cases, clearly demonstrating the role of early screening and detection of colorectal cancer – not only for the patient but also for family members.

Following the program, Dr. Nguyen Thi Cam Tu – Department of Gastroenterology & Hepatology – delivered a detailed and visual presentation on gastric cancer screening. She noted: “Gastric cancer has very diverse manifestations. Patients may experience weight loss, abdominal pain, difficulty swallowing, nausea... or may only vaguely feel loss of appetite, indigestion, or even no symptoms at all. Therefore, people should proactively get screened, and those in high-risk groups should undergo endoscopy every 1–2 years.”

A more concerning issue is that in Vietnam, the H. pylori infection rate reaches up to 80% of the population, while this is considered the most important risk factor for gastric cancer. Identifying and appropriately treating the infection is a crucial step to prevent chronic H. pylori infection from causing mucosal atrophy, metaplasia, dysplasia, and cancer.

Regarding treatment, Dr. Bui Quang Loc – Head of the Oncology Unit at �����ƽ�� – shared important updates on colorectal cancer treatment, covering surgery, chemotherapy, immunotherapy, and targeted therapy.

He emphasized: “Each colorectal cancer treatment regimen must be personalized based on various factors such as the patient's physical condition, other diseases and related conditions, disease stage, and tumor characteristics, including results from molecular biology tests. The latest research and updates from the Vietnamese Ministry of Health, the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the National Comprehensive Cancer Network (NCCN), and other reputable organizations have opened many promising avenues for treatment, extending survival and improving quality of life for patients.”

During the Q&A session, many guests confidently shared their digestive concerns and worries about cancer warning signs, reflecting the community’s growing interest in this common group of diseases.

Through this seminar, �����ƽ�� continues to affirm its commitment to accompanying the community in improving people’s quality of life.

We sincerely thank our valued guests for taking the time to attend the event. Your enthusiastic support is the driving force for �����ƽ�� to continue organizing even more meaningful events in the future.

-------

�����ƽ�� (�����ƽ��)

🏥 Address: No. 1 Phuong Mai, Dong Da, Hanoi

☎ Consultation Hotline: 024.35771100 – 0903497078

📱 Zalo OA: zalo.me/2008009049335817955